In Vitro Covalent Binding of New Brain Tracer, Para ¹²⁵ I-Amphetamine, to Rat Liver and Lung Microsomes

References

• Ackerman R. H. Cerebral blood flow, stroke and SPECT. Stroke (1984); 15: 1–4
   PubMed Web of Science ®Google Scholar
• Lassen N. A., Henriksen L., Holm S., Barry D. I., Paulson O. B., Vorstrup S., Rapin J. R., Leponcin Lafitte M., Moretti J. L., Askienazy S., Raynaud C. Cerebral blood flow tomography : Xe compared with isopropyl amphetamine iodine 123 : concise communication. J. Nucl. Med. (1983); 24: 17–21
   PubMed Web of Science ®Google Scholar
• Moretti J. L., Sergent A., Degos J. D., Caron J. P., Cesaro P., Nguyen J. P., Cavellier J. F., Iachetti D., Neuman A. Tomoscintigraphie cérébrale d'émission gamma appliquée a la neurologie. Ann. Radiol. (1984); 27: 693–699
   PubMedGoogle Scholar
• Blau M. Radiotracers for functionnal brain imaging. Seminars in Nuclear Medecine (1985); 15: 329–334
   PubMed Web of Science ®Google Scholar
• Rapin J. R., Le Poncin-Laffite M., Durterte D., Askienazy S., Lassen N., Moretti J. L., Raynaud C., Coornaert S., Bardy A., Desplanches G. Radiopharmacologic studies of isopropyl-iodoamphetamine. Functionnal Radionuclide Imaging of the brain, P. L. Magistretti. Raven press, New-York (1983); 211–218
   Google Scholar
• Hill T. C., Magistretti P. L., Holman B. L., Lee R. G.L., O'Leary D. H., Uren R. F., Royal H. D., Mayman C. I., Koiodny G. M., Ciousi M. E. Assessment of regional cerebral blood flow in stroke using SPECT andN-isopropyl-(I 123)-p-iodoamphetamine. Stroke (1984); 15: 40–45
   PubMed Web of Science ®Google Scholar
• Cohen M. B., Graham L. S., Lake R., Metter E. J., Fitten J., Kulkarni M. K., Sevrin R., Yamada L., Chang C., Woodruff N., Kling A. S. Diagnosis of Alzheimer's desease and multiple infarct dementia by tomographic imaging of iodine-123 IMP. J. Nucl. Med. (1986); 27: 769–774
   PubMed Web of Science ®Google Scholar
• Sharp P., Gemmell H., Cherryman G., Besson J., Crawford J., Smith F. Application of iodine-123-labeled isopropyliodoamphetamine imaging to the study of dementia. Nucl. Med. (1986); 27: 761–768
   Web of Science ®Google Scholar
• Jagust W. J., Budinger T. F., Reed B. R. The diagnosis of dementia with Single Photon Emission Computed Tomography. Arch. Neurol. (1987); 44: 258–262
   PubMed Web of Science ®Google Scholar
• Johnson K. A., Mueller S. T., Walshe T. M., English R. J., Holman B. L. Cerebral perfusion imaging in Alzheimer's desease. Arch. Neurol. (1987); 44: 165–168
   PubMedGoogle Scholar
• Moretti J. L., Askienazy S., Raynaud C., Lassen N., Sanabria E., Soussaline F., Bardy A., Le Poncin-Laffite M., Caron J. P., Chodkiewicz J. P. N-Isopropyl-123 I-p-Iodoamphetamine : An agent for brain imaging with single-photon emission computerized tomography. Functional Radionuclide Imaging of the brain, P. L. Magistretti. Raven Press, New York (1983); 231–246
   Google Scholar
• Royal D. H., Hill T. C., Holman B. L. Clinical brain imaging with isopropyliodoamphetamine and SPECT. Seminar in Nuclear Medicine (1985); 4: 357–376
   Web of Science ®Google Scholar
• Moretti J. L., Askienazy S., Raynaud C., Lassen N. A., Sanabria E., Desplanches C. L., Rapin J. R., Cesaro P., Marsault C. L., Barbizet J., Kerayel Y., Fredy D. La N-isopropyl-p-iodo-amphetamine I123 en tomoscintigraphie cérébrale. Ann. Radiol. (1983); 26: 59–67
   PubMedGoogle Scholar
• Baldwin R. M., Wu J. L., Lin T. H., Salazar N. E., Ma J. M., Look S., Vu CD., Borenstein J. S., Zreele S., Hain D., Felix M. J. Pharmacokinetics of 123 IN-isoropyl-p-amphetamine in humans. Current Concepts in Radiopharmacology, M. W. Billinghurst. Pergamon Press, New-York (1986); 35–41
   Google Scholar
• Baldwin R. M., Wu J. L. In vivo chemistry of iofetamine HC iodine-123 (IMP). J. Nucl. Med. (1988); 29: 122–124
   PubMed Web of Science ®Google Scholar
• Miller K. J., Anderholm D. C., Ames M. M. Metabolic activation of the serotoninergic neurotoxin para-chloramphetamine to chemically reactive intermediates by hepatic and brain microsomal preparations. Biochem. Pharmacol. (1986); 35: 1737–1742
   PubMed Web of Science ®Google Scholar
• Ames M., Frank S. K. Stereochemical aspects of para-chloro-amphetamine metabolism. Rabbit liver microsomal metabolism of RS-, R(-)-, and S(+)-para-chloroamphetamine. Biochem. Pharmacol. (1982); 31: 5–9
   PubMed Web of Science ®Google Scholar
• Gillette J. R. A perspective on the role of chemically reactive metabolites of foreign compounds on toxicity. I: correlation of changes in covalent binding of incidence and severity of toxicity. Biochem. Pharmacol. (1974); 23: 2785–2794
   PubMed Web of Science ®Google Scholar
• Gillette J. R. A perspective on the role of chemically reactive metabolites of foreign compounds on toxicity. II: alterations in the kinetics of covalent binding. Biochem Pharmacol. (1974); 23: 2927–2938
   PubMed Web of Science ®Google Scholar
• Fuller R. W., Snoddy S. D., Snoddy A. N., Hemrich S. K., Wong D. T., Molloy B. B. Para-iodoamphetamine as a serotonine depletors in rats. J. Pharmacol. Exp. Ther. (1980); 212: 115–119
   PubMed Web of Science ®Google Scholar
• Rapin J. R., Le Poncin-Laffite M., Duterte D., Rips R., Morier E., Lassen N. A. Iodoamphetamine as a new tracer for cerebral blood flow in the rat : comparison with Isopropyliodoamphetamine. J. Cereb. Blood Flow Metab. (1984); 4: 270–274
   PubMed Web of Science ®Google Scholar
• Moretti J. L., Zini R., Morin D., Joulin Y., Desplanches G., Caillat-Vigneron N., Tillement J. P. Interactions of phenyl alkyl amines with lung membranes and microsomeprepa-ration. Nucl. Med. Coram. (1987); 8: 115–120
   PubMed Web of Science ®Google Scholar
• Franklin M. R. A new class of inhibitory cytochrome P-450 complexes formed during metabolism: a comparaison with amphetamine and SKF 525-A type complexes. Chem. Biol. Interactions (1976); 14: 337–346
   PubMed Web of Science ®Google Scholar
• Wright J., Cho A. K., Gal J. The metabolism of amphetamine in vitro by Rabbit liver preparations : A comparison of R(-) and S(+) enantiomers. Xenobiotica (1977); 7: 257–266
   PubMed Web of Science ®Google Scholar
• Mansuy D., Beaune P., Chottard J. C., Bartoli J. F., Gans P. The nature of the ‘455 nm absorbing complex’ formed during the cytochrome P-450 dependent oxidative metabolism of amphetamine. Biochem. Pharmacol. (1976); 25: 609–612
   PubMed Web of Science ®Google Scholar
• Franklin M. R. The influence of cytochrome P-450 induction on the metabolic formation of 455 nm complexes from amphetamines. Drug Metab. Disp. (1974); 2: 321–326
   PubMed Web of Science ®Google Scholar
• Franklin M. R. The inhibition of the Mixed Function Oxidation reaction by amphetamines in liver and lung microsomes. Microsomes and drug oxidations, V. Ullrich, I. Roots, A. Hildebrandt, R. W. Eastbrook, A. H. Conney. Pergamon press, New-York (1977); 284–291
   Google Scholar
• Franklin M. R., Gumbrecht J. L. The formation of amphetamine metabolic intermediate complexes with cyt P-450 in microsome an intact tissues. Microsomes, Drug Oxidation and Chemical carcinogenesis, M. J. Coon, A. H. Conney, R. W. Estabrook, H. V. Gelboin, J. R. Gillette, P. J. O'Brien. Academic Press, New-York (1980); 829–832
   Google Scholar
• Franklin M. R. Complex of metabolites of amphetamines with hepatic cytochrome P-450. Xenobiotica (1974); 4: 133–139
   Web of Science ®Google Scholar
• Uehleke H. The role of the cytochrome P-450 in the N-oxidation of individual amines. Drug Met. Disp. (1973); 1: 299–312
   PubMed Web of Science ®Google Scholar
• Abernathy CO., Hodgson E., Guthrie F. E. Struture-activity relationships on the induction of hepatic microsomal enzymes in the mouse by 1,1,1-trichloro-2,2-bis(p-chlorophenyl)ethane (DDT) analogs. Biochem. Pharmacol. (1971); 21: 2385–2393
   Web of Science ®Google Scholar
• Omura T., Sato R. The carbon monoxide binding pigment of liver microsomes. J. Biol. Chem. (1964); 239: 2379–2385
   PubMed Web of Science ®Google Scholar
• Lowry O. H., Rosebrough N. J., Farr A. L., Randall R. J. Protein measurement with the Folin phenol reagent. J. Biol. Chem. (1951); 193: 265–275
   PubMed Web of Science ®Google Scholar
• Franklin M. R. Inhibition of hepatic oxidative xeniobiotics by pyperonyl-butoxide. Biochem. Pharmacol. (1972); 21: 3287–3292
   Web of Science ®Google Scholar
• Bulger W. H., Temple J. E., Kupfer D. Covalent binding of C methoxychlor metabolites to rat liver components. Toxicol. Appl. Pharmacol. (1983); 68: 367–374
   PubMed Web of Science ®Google Scholar
• Laemmli U. K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature (London) (1970); 227: 680–685
   PubMed Web of Science ®Google Scholar
• Shapiro A. L., Vinvela E., Maizel J. V. Molecular weight estimation of polypetide chains by electrophoresis in SDS polyacrylamide gels. Biochem. Biophys. Res. Commun. (1967); 28: 815–820
   PubMed Web of Science ®Google Scholar
• Ryan D. E., Thomas P. E., Parkinson A., Reik L. M., Wood A. W., Levin W. Characterization and regulation of rat hepatic microsomal cyt P-450 isozymes. First colloquium in Biological Sciences, New York (1984); 43: 5, 73–85
   Google Scholar
• Al-Gailany K. A., Houston J. B., Bridges J. W. The role of the substrate lipophilicity in determining type I microsomal P-450 binding characteristics. Biochem. Pharmacol. (1978); 27: 783–788
   PubMed Web of Science ®Google Scholar
• Sum C. Y., Cho A. K. The N-hydroxylation of phentermine by rat liver microsomes. Drug. Metab. Dispos. (1977); 7: 464–468
   Web of Science ®Google Scholar